SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-050749
Filing Date
2021-09-30
Accepted
2021-09-30 13:30:10
Documents
14
Period of Report
2021-09-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea148189-8k_inmedphar.htm   iXBRL 8-K 27826
2 NEWS RELEASE, DATED SEPTEMBER 30, 2021 ea148189ex99-1_inmedphar.htm EX-99.1 18997
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5348
  Complete submission text file 0001213900-21-050749.txt   232938

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20210930.xsd EX-101.SCH 3031
5 XBRL LABEL FILE inm-20210930_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inm-20210930_pre.xml EX-101.PRE 22364
7 EXTRACTED XBRL INSTANCE DOCUMENT ea148189-8k_inmedphar_htm.xml XML 3632
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211294587
SIC: 2834 Pharmaceutical Preparations